About BioVigilant
BioVigilant is a company based in Tucson (United States) founded in 2002 was acquired by Azbil in May 2009. BioVigilant has raised $6.4 million across 2 funding rounds from investors including Azbil, Alerion Capital Group and Iternal.
- Headquarter Tucson, United States
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Maine Potato Growers, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of BioVigilant
BioVigilant has successfully raised a total of $6.4M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $4 million completed in May 2006. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BioVigilant
BioVigilant has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Azbil, Alerion Capital Group and Iternal.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Private equity focused on tech companies
|
Locked | Locked | Locked |
Investor details for BioVigilant
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioVigilant
Investment portfolio details for BioVigilant
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioVigilant
Detailed financials for BioVigilant
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biovigilant Comparisons
Peer comparison for BioVigilant
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioVigilant
Detailed competitors of BioVigilant
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biovigilant
Complete news archive for BioVigilant
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioVigilant
BioVigilant was founded in 2002.
BioVigilant is headquartered in Tucson, United States. It is registered at Tucson, Arizona, United States.
BioVigilant is a funded company, having raised a total of $6.4M across 2 funding rounds to date.
BioVigilant was founded in 2002 in Tucson, United States, with a focus on microbial detection systems for sectors including pharmaceuticals and healthcare. Optically based IMD technology is utilized to identify particle count, size, and biological status without staining, reagents, or significant human input. A majority stake was acquired by Yamatake Corporation in 2009, leading to a name change in 2012, and 37 patents are held alongside 23 pending applications.
BioVigilant has 7 investors. Key investors include Azbil, Alerion Capital Group, Iternal, Pearl Street Venture Funds, and Community Investment Corporation.